Drug intelligence / Profile preview

polyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride

Development stage
Phase 4
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

This drug is a sulfate-free osmotic laxative combination used primarily for rapid bowel cleansing prior to colonoscopy or barium enema X-ray examinations. It consists of **polyethylene glycol (PEG) 3350**, a non-absorbable polymer, combined with a specific blend of electrolytes: **sodium bicarbonate**, **sodium chloride**, and **potassium chloride**. The mechanism of action relies on the osmotic activity of PEG 3350, which retains water in the intestinal lumen to induce a watery diarrhea that effectively clears the colon. The electrolyte composition is formulated to make the solution isosmotic with body fluids, ensuring that the administration of large volumes (typically 4 liters) results in virtually no net absorption or excretion of ions or water. This sulfate-free formulation was specifically developed by **Braintree Laboratories** (as NuLYTELY) to improve the taste and palatability compared to original PEG-electrolyte solutions (like GoLYTELY), thereby enhancing patient adherence and acceptance.

Brand names
NuLYTELYGaviLyte-NColopegTransipegTransipegLib
Other names
PEG-3350 and electrolytes (sulfate-free)macrogol 3350 and electrolytesmacrogol3350 and electrolytesmacrogol-3350 and electrolytessulfate-free PEG-electrolyte solutionpolyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution

Beyond the preview

Go deeper on polyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 3350 + sodium bicarbonate + sodium chloride + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call